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This study was designed to evaluate the effect of CoQ10 and vitamin E on serum total sialic acid (TSA), 
lipid bound sialic acid (LSA) and some elements in rat administered doxorubicin (DXR). Cu levels were 
increased in the group treated with DXR + vitamin E in comparison with DXR (p<0.05) and CoQ10 groups 
(p = 0.001). Furthermore, copper levels were increased in the group treated with DXR + CoQ10 in 
comparison with CoQ10 group (p < 0.05). Zn levels were decreased in the group treated with DXR + 
vitamin E in comparison with CoQ10 group (p < 0.05). Mg levels were decreased in subjects treated with 
DXR + vitamin E in comparison with the control group values (p < 0.05). Particularly, the observed 
increase in Cu levels in rats from DXR + vitamin E group might be due to the decrease of vitamin E. 
However, the oxidative damage could be as a result of DXR occurence and may be helpful to clinicians 
in chemotherapy using anthracycline. 
 





Doxorubicin (DXR) (also known as adriamycin or 14-
hydroxydaunorubicin) is an anthracycline-type antitumor 
(antineoplastic or cytostatic) drug that is used in chemo-
therapy for treatment of various cancers (Arcamone et al., 
1969). DXR is an effective anti-neoplastic agent, appli-
cation of which has been limited due to its cardiotoxic 
side effects (Balaei et al., 2010; Wold et al., 2005). The 
mechanism of DXR-induced cardiomyopathy remains 
unclear, but most of the evidence indicates that free 
radicals accompanied by a decrease of endogenous 
antioxidants and the subsequent increase in oxidants 
results in enhanced oxidative stress leading to a slow 
loss of myofibrils and vacuolization of myocardial cells 
which are the typical changes in the DXR-induced heart 
failure (Singal and Iliskovic, 1998). Furthermore, myocar-
dial damage may be caused by an increase in tissue 
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lipid peroxidation, the release of vasoactive amines, TNF-
a and interleukin-2, liberation of cytokine from the tumor, 
changes in adrenergic function, lysosomal alterations and 
the inhibition of the CoQ10 and the sodium-potassium-
activated ATPase (Simpson et al., 2004; Iarussi et al., 
2001). 
CoQ10 (ubiquinone) is a mitochondrial coenzyme which 
is essential for the production of ATP (Littarru, 1994; 
Kumar et al., 2009). Being at the core of cellular energy 
processes, it assumes importance in cells with high 
energy requirements like the cardiac cells which are 
extremely sensitive to CoQ10 deficiency produced by 
cardiac diseases. CoQ10 has thus, a potential role in the 
prevention and treatment of heart ailments by improving 
cellular bioenergetics (Kumar et al., 2009). Furthermore, 
CoQ acts as a potent antioxidant in the inner mitochondrial 
membrane. It inhibits lipid peroxidation by either scaven-
ging free radicals directly or reducing -tocopheroxyl 
radical to -tocopherol (Ernster and Dallner, 1995; Lass 
and Sohal, 1998).  
-Tocopherol is known to function in vivo as antioxidant 




and to provide cell membranes with protection against 
peroxidative and hydroxyl radical damage (Halliwell, 
1996). CoQ10H2 acts as a chain-breaking radical scaven-
ger (Kagan et al., 1990), synergizes with -tocopherol via 
reduction of the -tocopherol-derived phenoxyl radical 
(Kagan et al., 19902) and thus, inhibit tocopherol-mediated 
peroxidation (Bowry and Stocker, 1993).  
Serum sialic acid levels have been used as laboratory 
markers in a variety of pathological conditions (Kario and 
Matsuo, 1993; Hakamory, 1984). Sialic acid (SA), an 
important component of glycoproteins and glycolipids, is 
found in negatively charged surface polyanions on 
various cell membranes and plays an important role in 
the antigenic characterization of cells (Lehninger et al., 
1993). Total sialic acid (TSA) levels are elevated in many 
circumstances, such as myocardial infarction (Güngör et 
al., 2004; Succari et al., 1982), cancer (Seyrek et al., 2005), 
some auto-immune disorders (Maneva et al., 1995), 
diabetes mellitus (Crook et al., 1993), infections and 
chronic glomerulonephritis (Iler et al., 1993). 
Minerals and trace elements play a dual role in the 
biological system through their interaction with biomole-
cules (Strong and Garruto, 1994). In biological and 
medical research, the determination of the concentration 
of trace elements and minerals as well as their distribution 
pattern is extremely important since it could provide 
unique information about various physiological and 
patho-physiological processes in the investigated tissues 
(Seeley et al., 1996). Some trace elements, particularly 
copper and zinc are in fact implied in both humoral and 
cellular immunity (Berger et al., 1998). These essential 
micronutrients can interfere directly with the propagation 
stage of free radical generation and scavenge free 
radicals (Kulikowska and Moniuszko, 2004).  
So far, in literatures, there is no report related to the 
effect of CoQ10 and vitamin E on trace elements, sialic 
acid and lipid-bound sialic acid, despite the fact that 
several studies that are related to the effect of the other 
parameters on doxorubicin are available. The aim this 
study was to evaluate the effects of vitamin E and CoQ10 
treatment on serum total sialic acid, lipid-bound sialic 
acid, some trace element and mineral levels on DXR-
induced cardiotoxicity in rat model. 
 
 
MATERIALS AND METHODS 
 
Animals and drug administration protocols 
 
All procedures described were studied and approved by the Local 
Institutional Committee for the Ethical Use of Animals. Wistar albino 
rats (180 to 200 g) were used in these experiments. The rats were 
obtained from the Department of Virology, Firat University, Vete-
rinary Research Institute. All animals were housed in standard 
cages at room temperature (22 ± 2°C), with artificial light from 7.00 
am to 7.00 pm, and provided with standard pelleted food and water 
ad libitum.  
Rats were divided into four groups (n = 6/group). In the first 
group, DXR with 2.5 mg/kg normal saline were applied intraperi-





in addition to DXR, CoQ10 was applied intraperitoneally with the 
ratio of 4 mg/kg/live weight on daily bases. In the third group rats, 
only CoQ10 was applied with the ratio of 4 mg/kg/live weight on daily 
bases. In the fourth group rats, in addition to DXR, vitamin E was 
applied with the ratio of 10 mg/kg/subcutaneous two times a week 
for 6 weeks. The study period were planned as 6 weeks.  
 
 
Serum samples preparation 
 
Blood samples were collected at the beginning of application (0th) 
and at the 60th day of the application period by the intra cardiac 
method and centrifuged in 500 g-force (rpm) for 15 min to obtain 
sera which was later stored at -70°C until all experimental proce-





Serum TSA and serum lipid bound sialic acid (LSA) levels were 
measured by colorimetric method using ATI UNCAM UV/V 
spectrometer (Katopodis et al., 1982; Sydow, 1985). Serum trace 
element (Zn, Cu and Fe) and mineral (Ca, Mg and Na) concen-
trations were measured using a solar atomic absorption (Thermo 






Data are presented as X  ± SEM (standard error of mean). Diffe-
rences in biochemical parameters were statistically evaluated using 






No death was observed in any of the experimental groups. 
Average serum TSA, LSA, trace element (Fe, Cu and Zn) 
and mineral (Ca, Mg and Na) levels between groups are 
shown in Table 1 ( X  ± SEM) and Figures 1 to 3.  
 
 
Serum levels of TSA and LSA 
 
Data on the serum levels of TSA and LSA of the animals 
in the control, DXR, CoQ10, DXR + CoQ10 and DXR + 
vitamin E groups are summarized in Table 1 and Figure 
1. The levels of TSA and LSA among the different treat-
ment groups showed no difference as compared to the 
control group (p > 0.05).  
 
 
Serum levels of trace elements 
 
Data on the serum levels of trace elements (Fe, Cu and Zn) 
of the animals in the control, DXR, CoQ10, DXR + CoQ10 
and DXR + vitamin E groups are summarized in Table 1 
and Figure 2. The serum levels of Fe among the different 
treatment groups showed no difference when compared 
to the control group (P > 0.05). The serum levels of Cu 
was  increased  in  the  DXR  +  vitamin  E  treated  group  




Table 1. Average concentrations of TSA, LSA, trace element (Fe, Cu and Zn) and mineral (Ca, Mg and Na) levels in serum 




( X  ± SEM) 
DXR 
( X  ± SEM) 
CoQ10 
( X  ± SEM) 
DXR + CoQ10 
( X  ± SEM) 
DXR + Vit E 
( X  ± SEM) 
TSA (mg/dl) 80.48 ± 5.29 94.43 ± 7.21 79.32 ± 10.33 93.74 ± 6.19 86.02 ± 2.39 
LSA (mg/dl) 21.65 ± 0.29 23.59 ± 0.40 20.83 ± 0.83 22.39 ± 0.85 21.83 ± 0.47 
Fe (mg/L) 2.80 ± 0.34 2.61 ± 0.38 2.50 ± 0.17 1.71 ± 0.26 1.66 ± 0.43 
Cu (mg/L) 1.19 ± 0.06 0.97 ± 0.10b 0.75 ± 0.05a.b1 1.21 ± 0.12b1 1.44 ± 0.12a.b 
Zn (mg/L) 1.03 ± 0.07 0.93 ± 0.05 1.15 ± 0.03b 0.84 ± 0.09 0.78 ± 0.23b 
Ca (mg/dl) 11.25 ± 0.83 9.17 ± 0.60 9.96 ± 0.67 9.19 ± 1.04 11.39 ± 0.57 
Mg (mg/dl) 2.68 ± 0.14b 2.44 ± 0.20 2.47 ± 0.03 2.64 ± 0.32 1.88 ± 0.09b 
Na (mg/ml) 2.88 ± 0.03 2.77 ± 0.02 2.86 ± 0.02 2.79 ± 0.03 2.86 ± 0.05 
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Figure 1. Comparison of TSA and LSA levels in serum samples of the control, DXR, CoQ10, DXR + CoQ10 and 




when compared to DXR group (P < 0.01). Furthermore, it 
was increased in the DXR + vitamin E and DXR + CoQ10 
treated groups when compared to the CoQ10 group (P = 
0.001 and p < 0.05, respectively). The serum levels of Zn 
was decreased in the DXR + vitamin E treated group as 
compared to the CoQ10 group (P < 0.01). 
 
 
Serum levels of minerals 
 
Data on the serum levels of minerals (Ca, Mg and Na) of 
the animals in the control, DXR, CoQ10, DXR + CoQ10 
and DXR + vitamin E groups are summarized in Table 1 
and Figure 3. The serum levels of Ca and Na among the 
different  treatment   groups   showed   no   difference  as 
compared to the control group (p > 0.05). The serum levels 
of Mg was decreased in the DXR + vitamin E treated 





Cytostatic agents are known to exert their antitumour 
action by interacting with specific cell structures or 
metabolic pathways of cancer cells (Sangeetha et al., 
1990). Several studies have demonstrated the protective 
properties of various antioxidants against the harmful 
action of cytostatic drugs such as doxorubicin, and cisplatin 
in vitro (Miura et al., 1994). Experimental animal studies 
have  shown  that  the  co-administration  of   free  radical  







CoQ10 DXR + 
CoQ10  
 
Figure 2. Comparison of trace element (Fe, Cu and Zn) levels in serum samples of the control, DXR, CoQ10, DXR + 




CoQ10 DXR + 
CoQ10  
 
Figure 3. Comparison of mineral (Ca, Mg and Na) levels in serum samples of the control, DXR, CoQ10, DXR + CoQ10 and DXR 




scavengers did not reduce the antitumour effect of agents 
such as doxorubicin (Keizer et al., 1990; Siveski-Iliskovic 
et al., 1995).  
Cardiomyopathy and heart failure have been observed 
in  DXR-treated   cancer  patients  (Singal  and   Iliskovic, 
1998) The cardiotoxic effect of DXR are mediated via 
different mechanisms (Wang et al., 2004). Doxorubicin 
induced heart failure is associated with an increase in 
oxidative stress (Lou et al., 2006). Assaying sialic acid 





content has been reported to be altered in cardiovascular 
disease (Lindberg et al., 1991). It has been reported that 
plasma sialic acid concentrations are elevated in coro-
nary heart disease and myocardial infarction (Allain et al., 
1996; Crook et al., 1994). Deepa and Varalakshmi (2005) 
showed that the mean plasma sialic acid concentration in 
DXR- treated rats was significantly higher than those of 
the other treatment groups. In this study, serum TSA and 
LSA levels in the DXR group were increased in com-
parison with the control group. 
 The human body possesses several molecules that 
protect healthy tissues from the damaging action of free 
radicals (Halliwell and Gutteridge, 1993). Some trace 
elements have an important role in free radical protection. 
The trace elements are incorporated in the structures of 
the proteins, enzymes and complex carbohydrates to par-
ticipate in biochemical reaction. Trace elements with 
enzymes, for example, are necessary for the functioning 
and maintenance of the immune system (Bang et al., 
2002). Most enzymes contain trace elements, such as 
selenium in glutathione peroxidase and zinc and manga-
nese and copper in superoxide dismutase (Weijl et al., 
1997; Coudray et al., 1992). Overexpression of cardiac-
specific catalase prevents injury to the heart following 
oxidative insults such as exposure to the anticancer 
agent, doxorubicin (Kang et al., 1996). Cu deficiency can 
lead to reduction in catalase activity in tissues such as 
heart and liver (Strain, 1994). Chemical studies have shown 
that doxorubicin is a powerful iron chelator and the 
resultant iron-drug complex is an efficient catalyst of the 
conversion of hydrogen peroxide to the highly reactive 
hydroxyl radical (Ortega et al., 2001).  
The levels of Zn is associated with levels of Cu and Fe 
due to the antagonistic relationships between these 
metals (Disilvestro and Blostein-Fujii, 1997). It has been 
suggested that an imbalance between Cu and Zn may be 
a factor in the aetiology of cardiovascular diseases (Tiber 
et al., 1986). Costa and Nepomuceno (2006) reported 
that minerals such as Cu and Zn protects the organism 
against the genotoxic effects of chemotherapeutics such 
as DXR. Morishima et al. (1999) reported that DXR 
decreased plasma zinc levels in rat. We observed a 
significant increase in the levels of Cu following DXR + 
vitamin E treatment group as compared to DXR group. 
Furthermore, the serum levels of Zn was decreased in 
the DXR + vitamin E treated group as compared to CoQ10 
group.  
Eckenhoff and Somlyo (1998) reported that the levels 
of mitochondrial Ca and Mg did not change in the DXR-
injected animals, even in severely symptomatic rats 5 
days after DXR administration. In this study, the serum 
levels of Mg decreased in the DXR + vitamin E treated 
group as compared to the control group. 
The results of this study indicated that serum TSA and 
LSA levels in the DXR group were increased in com-
parison with the control group. The levels of TSA and 
LSA  were lower in the CoQ10 and vitamin E groups when  




compared with the DXR group. Particularly, the observed 
increase in the Cu levels in rats from DXR + vitamin E 
group might be due to the decrease of vitamin E. 
However, the oxidative damage could be as a result of 
DXR occurence and may be helpful to clinicians in 
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